Eli Lilly Launches Weight-Loss Drug Mounjaro In India
The recent launch of Mounjaro by Eli Lilly in India brings a breath of fresh air for individuals managing both weight and type 2 diabetes. The dual-action medication targets both insulin regulation and weight reduction, making it a revolutionary addition to the treatment landscape. In a country where sedentary lifestyles and dietary habits are leading to a surge in obesity and metabolic disorders, Mounjaro provides a powerful, science-backed solution. This medication can help patients achieve sustainable health goals alongside proper diet and exercise.